Catherine L. Salussolia, MD, PhD
Attending, Epilepsy Center, Boston Children's Hospital; Instructor of Neurology, Harvard Medical School
Genetic Etiologies, Diagnosis, and Treatment of Tuberous Sclerosis Complex.
Salussolia CL, Klonowska K, Kwiatkowski DJ, Sahin M
Annu Rev Genomics Hum Genet. 2019 Aug 31;20:217-240. doi: 10.1146/annurev-genom-083118-015354. Epub 2019 Apr 24.PMID: 31018109 Review.
Treatment-Resistant Epilepsy and Tuberous Sclerosis Complex: Treatment, Maintenance, and Future Directions.
Singh A, Hadjinicolaou A, Peters JM, Salussolia CL.
Neuropsychiatr Dis Treat. 2023 Apr 5;19:733-748. doi: 10.2147/NDT.S347327. eCollection 2023.PMID: 37041855
Loss of Tsc1 in cerebellar Purkinje cells induces transcriptional and translation changes in FMRP target transcripts.
Dalal JS, Winden KD, Salussolia CL, Sundberg M, Singh A, Pham TT, Zhou P, Pu WT, Miller MT, Sahin M
Elife. 2021 Jul 14;10:e67399. doi: 10.7554/eLife.67399.PMID: 34259631
Translating Ribosome Affinity Purification (TRAP) of Cell Type-specific mRNA from Mouse Brain Lysates.
Salussolia CL, Winden KD, Sahin M.
Bio Protoc. 2022 May 5;12(9):e4407. doi: 10.21769/BioProtoc.4407. eCollection 2022 May 5.PMID: 35800463
Divergent roles of a peripheral transmembrane segment in AMPA and NMDA receptors.
Amin JB, Salussolia CL, Chan K, Regan MC, Dai J, Zhou HX, Furukawa H, Bowen ME, Wollmuth LP.J
J Gen Physiol. 2017 Jun 5;149(6):661-680. doi: 10.1085/jgp.201711762. Epub 2017 May 15.PMID: 28507080